BIO-key International
BKYI
18 hedge funds and large institutions have $961K invested in BIO-key International in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
1,400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 1
350% more funds holding
Funds holding: 4 → 18 (+14)
280% more capital invested
Capital invested by funds: $253K → $961K (+$708K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$508K |
| 2 |
Millennium Management
New York
|
+$292K |
| 3 |
Jane Street
New York
|
+$96.4K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$65.2K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$60.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$13K |
BKYI Hedge Fund Activity: Q3 2020 in Review
18 of the 4,860 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q3 2020, worth a combined $961K — up 280% from $253K a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new BKYI positions and 1 closed out — a net gain of 14 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $508K. The largest seller was Citadel Advisors, exiting entirely with an estimated $13K sold.
- 18 institutional investors held BIO-key International (BKYI) as of Q3 2020, up from 4 in Q2 2020.
- Funds reported $961K of BIO-key International stock for Q3 2020, up 280% quarter-over-quarter.
- 15 funds opened new BIO-key International positions in Q3 2020 and 1 closed out, a net change of +14 holders.
- The largest BIO-key International buyer in Q3 2020 was Renaissance Technologies, an estimated $508K added.
- The largest BIO-key International seller in Q3 2020 was Citadel Advisors, an estimated $13K sold.
Based on aggregated 13F filings for Q3 2020.